Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy in Open, Multicenter Phase IV Clinical Studies

NCT03210324 is registered in ClinicalTrials.gov with China Resources Zizhu Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT03210324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03210324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy in Open, Multicenter Phase IV Clinical Studies
Lead sponsor
China Resources Zizhu Pharmaceutical Co., Ltd.
Phase
Phase 4
Overall status
Terminated
Start date
June 1, 2017
Completion date
July 12, 2019
Enrollment
434 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

uterine fibroid